| Literature DB >> 35876501 |
Enrique Joffré1, Xue Xiao2, Mário S P Correia3, Intawat Nookaew4, Samantha Sasse3, Daniel Globisch3, Baoli Zhu2, Åsa Sjöling1.
Abstract
Enterotoxigenic Escherichia coli (ETEC) is a major cause of diarrhea in children and adults in endemic areas. Gene regulation of ETEC during growth in vitro and in vivo needs to be further evaluated, and here we describe the full transcriptome and metabolome of ETEC during growth from mid-logarithmic growth to early stationary phase in rich medium (LB medium). We identified specific genes and pathways subjected to rapid transient alterations in gene expression and metabolite production during the transition from logarithmic to stationary growth. The transient phase was found to be different from the subsequent induction of early stationary phase-induced genes. The transient phase was characterized by the repression of genes and metabolites involved in organic substance transport. Genes involved in fucose and putrescine metabolism were upregulated, and genes involved in iron transport were repressed. Expression of toxins and colonization factors were not changed, suggesting retained virulence from mid-logarithmic to the start of the stationary phase. Metabolomic analyses showed that the transient phase was characterized by a drop of intracellular amino acids, e.g., l-tyrosine, l-tryptophan, l-phenylalanine, l-leucine, and l-glutamic acid, followed by increased levels at induction of stationary phase. A pathway enrichment analysis of the entire combined transcriptome and metabolome revealed that significant pathways during progression from logarithmic to early stationary phase are involved in the degradation of neurotransmitters aminobutyrate (GABA) and precursors of 5-hydroxytryptamine (serotonin). This work provides a comprehensive framework for further studies on transcriptional and metabolic regulation in pathogenic E. coli. IMPORTANCE We show that E. coli, exemplified by the pathogenic subspecies enterotoxigenic E. coli (ETEC), undergoes a stepwise transcriptional and metabolic transition into the stationary phase. At a specific entry point, E. coli induces activation and repression of specific pathways. This leads to a rapid decrease of intracellular levels of certain amino acids. The resulting metabolic activity leads to an intense but short peak of indole production, suggesting that this is the previously described "indole peak," rapid decrease of intermediate molecules of bacterial neurotransmitters, increased putrescine and fucose uptake, increased glutathione levels, and decreased iron uptake. This specific transient shift in gene expression and metabolome is short-lived and disappears when bacteria enter the early stationary phase. We suggest that these changes mainly prepare bacteria for ceased growth, but based on the pathways involved, we could suggest that this transient phase substantially influences survival and virulence.Entities:
Keywords: E. coli; ETEC; Escherichia coli; Luria-Bertani broth; diarrheal pathogen; growth phases; metabolomics; neurotransmitter precursors; transcriptomics; transient growth phase
Mesh:
Substances:
Year: 2022 PMID: 35876501 PMCID: PMC9431495 DOI: 10.1128/spectrum.01755-21
Source DB: PubMed Journal: Microbiol Spectr ISSN: 2165-0497
FIG 1Growth curve of ETEC strains. Total bacterial counts in CFU (CFU/mL) and optic density (OD600) of the ETEC strains E2265 and E1777 in LB media. Samples were measured every hour for 6 h and after 12 h of incubation.
FIG 2Transcriptomic response of ETEC during bacterial growth transition from mid-exponential to early stationary phase. (a) Heatmap of the differential expressions of the two strains E1777 and E2265 after 3, 4, and 5 h of growth in LB medium. K-mers analysis indicated four main clusters (I-IV). (b) STEM analysis identifying the most common patterns of gene expression. (c) GO biological process enrichment analysis of significant genes per cluster and fold enrichment. (d) Examples of genes with transient up or downregulation.
FIG 3Intracellular and secreted profile of the metabolic response to ETEC during bacterial growth transition from mid-exponential to early stationary phase. (a) PCA plot generated from all metabolites of different samples. (b) Venn diagrams of number of significant metabolites (padj < 0.05 −2 > Log2Foldchange <2) found in the bacteria (intracellular) or medium (secreted). (c) Heatmap representation of the 35 differentially changed metabolites at any time point. The metabolite abundance per time point was used to generate the heatmap, and Z-score was scaled for visualization. (d) Pathway enrichment analysis of the intracellular and secreted significant metabolites. Non-significant pathways were colored gray. (e) Metabolite-metabolite correlation analysis shows positive correlations in dark purple and negative correlations in yellow. Secreted and intracellular metabolites were marked with orange and gray dots, respectively.
Summary of significantly altered intracellular and secreted metabolites of ETEC
| Metabolite | Classification | HMDB ID | Intracellular | Secreted | Pathways | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E1777 | E2265 | E1777 | E2265 | Aminoacyl-tRNA biosynthesis | Butanoate metabolism | Ala, Asp, and Glumetabolism | Arg and Pro metabolism | Glycolys is/Gluconeogenesis | Glutathione metabolism | Purine metabolism | Gly, Ser, and Thr metabolism | Methano metabolism | Nicotine/Nicotinamide metabolism | Vitamin B6 metabolism | Thiamine metabolism | phenylalanine metabolism | Pyrimidine metabolism | Muropeptide degradaation | Peptidoglycan biosynthesis | NF | |||||||
| 3 h vs 4 h | 3 h vs 5 h | 3 h vs 4 h | 3 h vs 5 h | 3 h vs 4 h | 3 h vs 5 h | 3 h vs 4 h | 3 h vs 5 h | ||||||||||||||||||||
| L-Glutamic acid | Amino acids and peptides | HMDB0000148 |
| −0.73 | −1.76 | −1.15 |
|
|
|
| X | X | X | X | |||||||||||||
| L-Tyrosine | Amino acids and peptides | HMDB0000158 |
| −0.11 |
| −0.99 |
|
|
| 0.25 | X | ||||||||||||||||
| Succinic acid | TCA acids | HMDB0000254 |
| −0.36 |
|
| −0.51 | −0.43 |
|
| X | X | |||||||||||||||
| L-Arginine | Amino acids and peptides | HMDB0000517 |
| −0.48 |
| −1.79 |
| −0.03 | 0.15 |
| X | X | |||||||||||||||
| L-Leucine | Amino acids and peptides | HMDB0000687 |
| −0.10 | −0.41 | 0.27 |
| 0.21 |
| 0.45 | X | ||||||||||||||||
| L-Phenylalanine | Amino acids and peptides | HMDB0000159 |
| −0.03 |
| −0.79 |
| −0.02 | 0.01 |
| X | ||||||||||||||||
| L-Tryptophan | Amino acids and peptides | HMDB0000929 |
| −0.04 |
| −1.12 |
| −0.04 |
| −0.06 | X | X | |||||||||||||||
| N-Acetyl-L-aspartic acid | Amino acids and peptides | HMDB0000812 |
|
| 0.59 | −0.17 | 0.01 | 0.12 | 0.02 | 0.43 | X | ||||||||||||||||
| S-Adenosylmethionine | Glycosyl compounds | HMDB0001185 | 1.46 |
| −0.05 | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 | X | ||||||||||||||||
| D-Glucose | Monosaccharides | HMDB0000122 |
| −0.35 | −1.94 | −1.40 | −0.03 | 0.01 | 0.07 | 0.02 | X | ||||||||||||||||
| Glutathione | Amino acids and peptides | HMDB0000125 |
|
| 3.56 |
| 0.00 | 0.00 | 0.00 | 0.00 | X | ||||||||||||||||
| Oxidized glutathione | Amino acids and peptides | HMDB0003337 |
|
|
|
| 0.40 | 0.48 |
|
| X | ||||||||||||||||
| GMP | Purines | HMDB0001397 | 0.23 |
| 1.60 |
| 0.00 | 0.00 | 0.00 | 0.00 | X | ||||||||||||||||
| Xanthine | Purines | HMDB0000292 |
| −0.03 | 1.14 | 0.76 | 0.06 | 0.11 | 0 | 0 | X | ||||||||||||||||
| N-methyl-L-glutamic Acid | Amino acids and peptides | HMDB0062660 |
|
| 0.00 | 0.00 | 0.63 | 0.58 | 0.00 | 0.00 | X | ||||||||||||||||
| NAD | Nicotinamides | HMDB0000902 |
| −0.05 |
|
| 0.01 | 1.14 |
|
| X | ||||||||||||||||
| Pyridoxal 5′-phosphate | Pyridine carboxaldehydes | HMDB0001491 |
| 1.06 |
|
| 0.00 | 0.00 | 0.00 | 0.00 | X | ||||||||||||||||
| Thiamine | Pyrimidines | HMDB0000235 |
| −0.23 | −1.29 | −0.99 | 0.07 | 0.06 | 0.09 | 0.08 | X | ||||||||||||||||
| trans-Cinnamic acid | Cinnamic acids | HMDB0000930 | −0.52 | −0.72 | 0.15 |
| 0.16 | 0.05 | −0.03 |
| X | ||||||||||||||||
| Uridine | Pyrimidines | HMDB0000296 |
| −0.48 | −0.91 |
| 0.03 | 0.02 | 0.00 | 0.00 | X | ||||||||||||||||
| Leucyl-Alanine | Amino acids and peptides | HMDB0028922 |
| 0.02 | −1.21 |
| 0.57 | 0.61 | 0 | 0 | X | ||||||||||||||||
| N-Acetylcadaverine | Carboxylic acids | HMDB0002284 | 0.30 |
| 1.25 |
| 1.68 | 0.76 | 0.00 | 0.00 | X | ||||||||||||||||
| Desaminotyrosine | Phenylpropanoids | HMDB0002199 | −0.49 | −0.64 | 0.31 |
| 0.29 | 0.17 | 0.01 |
| X | ||||||||||||||||
| 5-Aminopentanoic acid | Fatty acids | HMDB0003355 | 0 | 0 | 0.71 | 1.10 | 0 | 0 | −0.85 |
| X | ||||||||||||||||
| Adenosine | Purines | HMDB0000050 |
| −0.03 | −0.31 | −0.82 |
| 0.03 |
|
| X | ||||||||||||||||
| Alanyl-Phenylalanine | Amino acids and peptides | HMDB0028694 |
| −0.06 |
|
|
| −1.49 |
|
| X | ||||||||||||||||
| Betaine | Amino acids and peptides | HMDB0000043 | 0 | 0 | 0.17 | 0.09 | 0 | 0 | −1.28 |
| X | ||||||||||||||||
| L-Homoserine | Amino acids and peptides | HMDB0000719 | 0 | 0 |
| −1.72 | −0.29 | 0.00 | −0.69 |
| X | ||||||||||||||||
| Alanyl-Glutamine | Amino acids and peptides | HMDB0028685 |
| −0.26 |
|
|
| −1.12 | −1.13 |
| X | ||||||||||||||||
| D-Alanine | Amino acids and peptides | HMDB0001310 |
|
| −1.24 |
| −0.32 | −0.02 | −1.19 |
| X | ||||||||||||||||
| Spermidine | Amines | HMDB0001257 | 0 | 0 | 0 | 0 | 0 | 0 | −0.81 |
| X | ||||||||||||||||
| GABA | Amino acids and peptides | HMDB0000112 |
| −0.24 | −1.77 | −1.31 |
| −1.35 | −0.82 |
| X | X | X | ||||||||||||||
| Maleic acid | Fatty acids | HMDB0000176 |
| −0.71 | −1.20 | −0.94 | 0.34 | 0.52 |
|
| X | X | |||||||||||||||
| N-Acetyl-L-alanine | Amino acids and peptides | HMDB0000766 | 0 | 0 | 0 | 0 | −0.07 | 0.02 |
|
| X | ||||||||||||||||
| NADH | Nicotinamides | HMDB0001487 | 0.86 |
| −0.67 |
| 0.00 | 0.00 | 0.00 | 0.00 | X | ||||||||||||||||
Metabolites were classified based on their biochemical structure and role in metabolic pathways. Metabolite abundance is presented in fold change against 3 h. Values in bold represent −2 > Log2Foldchange > 2 and underlined were statistically significant Padj < 0.05.
X, associated metabolic pathways.
FIG 4Transcriptomic and metabolic modulation of 4-butanoate degradation, related pathways, and Aminoacyl-tRNA biosynthesis of ETEC during growth. Circles are metabolites, and arrows are reactions. Verified metabolites are labeled in bold (Table S13). The color of the thick arrows indicates the levels of gene expression represented in the fold change. The first and second arrows represent the fold change between 3 h versus 4 h and 3 h versus 5 h, respectively. Concentrations of significant metabolites are represented in the serial charts. The metabolite concentration is adjusted to 3 h, and the data is presented in foldchange ±SD.